NxStage Medical Inc.
NXTM
NXTM was delisted on the 21st of February, 2019.
139 hedge funds and large institutions have $837M invested in NxStage Medical Inc. in 2015 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 62 increasing their positions, 35 reducing their positions, and 12 closing their positions.
674% more call options, than puts
Call options by funds: $17.7M | Put options by funds: $2.29M
150% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 12
77% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 35
14% more funds holding
Funds holding: 122 → 139 (+17)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
16% less capital invested
Capital invested by funds: $992M → $837M (-$155M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIM
RS Investment Management
San Francisco,
California
|
+$19M |
| 2 |
DM
Deerfield Management
New York
|
+$11.9M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$9.38M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$7.45M |
| 5 |
Millennium Management
New York
|
+$6.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$23.9M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$21M |
| 3 |
O
OppenheimerFunds
New York
|
-$14.1M |
| 4 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
-$13.6M |
| 5 |
CM
Castleark Management
Chicago,
Illinois
|
-$9.96M |
NXTM Hedge Fund Activity: Q2 2015 in Review
139 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q2 2015, worth a combined $837M — down 16% from $992M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new NXTM positions and 12 closed out — a net gain of 18 holders — while 62 added to existing stakes and 35 trimmed.
The largest buyer was RS Investment Management, adding an estimated $19M. The largest seller was Fidelity Investments, cutting an estimated $23.9M.
- 139 institutional investors held NxStage Medical Inc. (NXTM) as of Q2 2015, up from 122 in Q1 2015.
- Funds reported $837M of NxStage Medical Inc. stock for Q2 2015, down 16% quarter-over-quarter.
- 30 funds opened new NxStage Medical Inc. positions in Q2 2015 and 12 closed out, a net change of +18 holders.
- The largest NxStage Medical Inc. buyer in Q2 2015 was RS Investment Management, an estimated $19M added.
- The largest NxStage Medical Inc. seller in Q2 2015 was Fidelity Investments, an estimated $23.9M sold.
Based on aggregated 13F filings for Q2 2015.